Dermatology and Allergic Disease Grants
The AKC Canine Health Foundation is committed to canine health by seeking critical research to diagnose, prevent and/or treat dermatological and allergic disease in dogs. The Foundation supports novel and multi-disciplinary approaches to addressing the health needs of all dogs.
Active Grants:
03215-A | Investigation of the Role of Staphylococcus pseudintermedius Phenol-soluble Modulins in Canine Pyoderma |
03162 | Fecal Microbiota Transplantation for Treatment of Canine Atopic Dermatitis |
03166-A | Evaluation of the Effects of Diluted Sodium Hypochlorite on Skin Microbiome in Dogs with Superficial Pyoderma and Atopic Dermatitis: a Single Blinded, Randomized, Controlled Clinical Trial |
02837 | Duration of Antibiotic Therapy for Canine Superficial Pyoderma: Is the One-Week Post Resolution of Clinical Signs a Valid Rule-of-Thumb? |
Previously Awarded Grants:
02694 | Investigation on the Molecular Crosstalk between Canine Atopic Skin and Microbes: Unraveling Potential Pathomechanisms for Chronic Recurrent Skin Infections |
02921-MOU | Transcriptome Profiling of Canine Familial Dermatomyositis Skin Lesions and Treatment with a JAK Inhibitor to Identify Novel Pathways Involved in Pathogenesis |
02673-MOU | Searching for the Cause for Alopecia X by Whole Genome Sequencing |
02829 | Investigating the Potential of Phage Therapy to Tackle Staphylococcus pseudintermedius Infections in Dogs |
02597 | Molecular Epidemiology of Methicillin-resistant Staphylococcus pseudintermedius in the United States |
02825-A | Effect(s) of Atopic Dermatitis-associated Cytokines on Staphylococcus pseudintermedius |
02651 | Discovery of Novel Biomarkers of Canine Atopic Dermatitis through Lipid Profiling |
02653-A | Evaluation of the Serum and Cutaneous Levels of Chemokines in Atopic Dogs |
02241 | The City Dog Study: Dermatologic and Respiratory Disease among Inner-City Dogs Living in the Homes of Children with Asthma |
02472-A | Effect of Lokivetmab on Tissue Biomarkers of Canine Atopic Dermatitis using RNA Sequencing |
02176-A | Intralymphatic Immunotherapy for the Treatment of Canine Atopic Dermatitis |
02182-A | Is Defective Secretion of Antimicrobial Peptides Associated with Reduced Microbicidal Effects in Atopic Keratinocytes? |
02261-MOU | Improvement of Risk Assessments for Dermatomyositis Testing |
02116-A | Establishing Best Practices in the Treatment of Atopic Dermatitis to Prevent Antimicrobial Resistance |
02111-A | Evaluating the Contribution of Fungal Infection to the Pathogenesis of Atopic Dermatitis: Putting Evidence under the Use of Antifungal Medication |
01746-A | Discovery of the Genetic Cause of Lethal Acrodermatitis |
01586 | Identifying the Genetic Cause of Sebaceous Adenitis |
01620 | Targeting Immune Cells as a Novel Treatment for Canine Atopic Dermatitis |
01591 | Identification of the Genes That Confer Risk for Atopic Dermatitis |
01421 | Genomic Resources for the Control of Canine Pyoderma |
01415 | Development of Anti-IgE Peptide for Treatment of Canine Allergy |
01663-A | Placebo-controlled trial of T-cell receptor (TCR) peptide treatment in dogs with non-responsive atopic dermatitis |
01547-A | Genetic Analysis of Alopecia X in Pomeranians |
01346-A | Genetic Basis of Sebaceous Adenitis in Dogs |
01240-A | Development of a Diagnostic Method for Canine Atopic Dermatitis |
The AKC Canine Health Foundation funds research in 23 different Research Program Areas for the health of all dogs. These program areas enable the Foundation to create depth in our research portfolio and help us to be responsive to the health concerns of our constituents.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.